Previous close | 1.3100 |
Open | 1.3000 |
Bid | 1.3400 x 400 |
Ask | 1.3700 x 400 |
Day's range | 1.2800 - 1.3600 |
52-week range | 0.5900 - 11.1200 |
Volume | |
Avg. volume | 1,020,178 |
Market cap | 95.495M |
Beta (5Y monthly) | 0.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Aclaris (ACRS) delivered earnings and revenue surprises of 14.29% and 20.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Here is how Aclaris Therapeutics (ACRS) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.